• Home
  • Sitemap
  • About Us
  • Our Services
  • Health News
  • Careers
  • Contact Us
  • Continuing Medical Education
  • Medical Journals
  • Health News
  • Special Reports
  • Consulting
  • Recruiting
  • Education

Medical Journals

  • Been There, Not Done That — Melanoma in the Age of Molecular Therapy. NEJM 2011 (NEJMe1105792)
  • Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation. NEJM 2011 (NEJMoa1103782)
  • Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma. NEJM 2011 (NEJMoa1104621)
  • Boceprevir for Untreated Chronic HCV Genotype 1 Infection. NEJM 2011 (NEJMoa1010494)
  • Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection. NEJM 2011 (NEJMoa1009482)
  • Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection. NEJM 2009 (NEJMoa0807650)
  • Telaprevir for Previously Treated Chronic HCV Infection. NEJM 2011 (NEJMoa0908014)

 

  • Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer.  NEJM 2009 (10.1056/NEJMoa0809003)
  • Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis.  NEJM 2009 (10.1056/NEJMoa0809493)
  • Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma.  NEJM 2009;361:947-957.
  • Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer.  NEJM 2009;361:958-967.
  • Combined Targeted Treatment to Eliminate Tumorigenic Cancer Stem Cells in Human Pancreatic Cancer.  Gastroenterology 2009;137:1102-1113.
  • Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy.  JAMA 2009;302:849-857.
  • Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes.  NEJM 2009 (10.1056/NEJMoa0904327)
  • Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance; for African-Americans, Hispanics, East Asians. Nature 2009 doi:10.1038/nature08309
  • Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection.  NEJM 2009 (10.1056/NEJMoa0808010)
  • Decline in Male Sexual Desire, Function, and Satisfaction During and After Antiviral Therapy for Chronic Hepatitis C.  Gastroenterology 2009;137:873-884.
  • Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma.  NEJM 2009 (10.1056/NEJMoa0905360)
  • Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials.  Lancet 2009 doi:10.1016/S0140-6736(09)61525-7
  • Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1/2 study.  Lancet 2009 doi:10.1016/S0140-6736(09)60945-4
  • Comparison of intravenous alteplase with a combined intravenous—endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study.  Lancet 2009 doi:10.1016/S1474-4422(09)70182-6
  • Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial.  Lancet doi:10.1016/S0140-6736(09)60250-6

Internal Medicine (more) 
  • Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients. NEJM 2008;359:2417-2428.
  • Hypersensitivity reactions to human papillomavirus vaccine in Australian schoolgirls: retrospective cohort study. BMJ doi:10.1136/bmj.a2642
  • Inhaled Corticosteroids in Patients With Stable Chronic Obstructive Pulmonary Disease. JAMA 2008;300:2407-2416.
  • Thrombolytic Therapy and Mortality in Patients With Acute Pulmonary Embolism. Arch Intern Med 2008;168:2183-2190.
  • Comparative Effectiveness of Different β-Adrenergic Antagonists on Mortality Among Adults With Heart Failure in Clinical Practice. Arch Intern Med 2008;168(22):2415-2421.
  • Clinical Effectiveness of Beta-Blockers in Heart Failure.  J Am Coll Cardiol  2009;53:184-192.
  • Impact of Statin Therapy on Central Aortic Pressures and Hemodynamics.  Circulation 2009;119:53-61.
  • Genetic Determinants of Response to Clopidogrel and Cardiovascular Events. NEJM 10.1056/NEJMoa0808227
  • Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon. NEJM 2008;359:2429-2441.
  • Peginterferon Alfa-2a and Ribavirin in Latino and Non-Latino Whites with Hepatitis C.  NEJM 2009;360:257-267.
  • Analysis of CD8+ T-Cell–Mediated Inhibition of Hepatitis C Virus Replication Using a Novel Immunological Model. Gastroenterology 2009;136:1391-1401.
  • Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival.  NEJM 2009;360:1815-1826.
  • Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.  Lancet doi:10.1016/S0140-6736(09)60612-7

Oncology (more)
  • Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study.  Lancet Oncol  doi:10.1016/S1470-2045(09)70002-6
  • Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer.  J Clin Oncol DOI:10.1200/JCO.2008.20.8397.
  • A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer.  J Clin Oncol DOI:10.1200/JCO.2008.19.8135.
  • Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease.  Gastroenterology 2009;136:138-148.
  • Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.  Lancet Oncol doi:10.1016/S1470-2045(08)70285-7
  • Sorafenib in Hepatocellular Carcinoma: Separating the Hype From the Hope. J Clin Oncol DOI:10.1200/JCO.2008.19.7996
  • Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia.  NEJM 10.1056/NEJMoa0808253
  • A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study.  Lancet Oncol doi:10.1016/S1470-2045(08)70339-5
  • Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial.  Lancet doi:10.1016/S0140-6736(08)61815-2
  • Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I—II study.  Lancet Oncol doi:10.1016/S1470-2045(09)70074-9
  • Hearing Improvement after Bevacizumab in Patients with Neurofibromatosis Type 2.  NEJM 2009;361:358-367.
  • Phase III Study of Gemcitabine Plus Docetaxel Compared With Capecitabine Plus Docetaxel for Anthracycline-Pretreated Patients With Metastatic Breast Cancer.  J Clin Oncol 10.1200/JCO.2007.15.8485

Neurology (more)
  • Effect of urgent treatment for transient ischaemic attack and minor stroke on disability and hospital costs (EXPRESS study): a prospective population-based sequential comparison.  Lancet Neurol  doi:10.1016/S1474-4422(09)70019-5
  • Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study.  Lancet Neurol  doi:10.1016/S1474-4422(09)70017-1
  • Epilepsy and Cognitive Impairments in Alzheimer Disease.  Arch Neurol  doi:10.1001/archneurol.2009.15
  • Different Patterns of Cerebral Injury in Dementia With or Without Diabetes.  Arch Neurol doi:10.1001/archneurol.2008.579
  • Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol doi:10.1016/S1474-4422(08)70263-1
  • Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial. The Lancet doi:10.1016/S0140-6736(08)61626-8.
  • Novel anti-angiogenic therapies for malignant gliomas. Lancet Neurol doi:10.1016/S1474-4422(08)70260-6.
  • Heterogeneity in Response to Interferon Beta in Patients With Multiple Sclerosis. Arch Neurol  doi:10.1001/archneur.66.1.noc80047
  • Decrease in the Numbers of Dendritic Cells and CD4+ T Cells in Cerebral Perivascular Spaces Due to Natalizumab. Arch Neurol doi:10.1001/archneur.65.12.noc80051
  • Genomewide Association Studies of Stroke. NEJM 10.1056/NEJMoa0900094
  • Mutations in THAP1 (DYT6) in early-onset dystonia: a genetic screening study.  Lancet Neurol doi:10.1016/S1474-4422(09)70081-X

Medical Journal Links:
  • Anesthesiology
  • Archives of Pathology and Laboratory Medicine
  • British Medical Journal
  • Chinese Medical Journal
  • Circulation
  • Gastroenterology
  • JAMA & Archives
  • Journal of the American College of Cardiology
  • Journal of Clinical Oncology
  • New England Journal of Medicine
  • Nature
  • Science Magazine
  • The Lancet
 Citations Search:
  • Medline PubMed


Copyright © 2009 Bownes & Lu, LLC All rights reserved.
  • Terms of Use
  • Privacy Policy